Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -31.79%5.09B | -25.03%3.63B | -30.59%1.72B | -18.97%11.08B | -29.67%7.46B | -31.76%4.85B | -25.28%2.47B | -44.36%13.67B | -51.18%10.61B | -57.46%7.1B |
| Refunds of taxes and levies | -59.14%19.37M | -58.96%18.23M | -47.36%17.81M | -55.42%74.23M | 49.61%47.4M | 53.92%44.43M | --33.84M | 282.60%166.51M | 109.18%31.68M | 218.48%28.87M |
| Cash received relating to other operating activities | -45.63%1.01B | -44.39%713.84M | -36.01%348.54M | -66.18%1.47B | -36.50%1.86B | -50.62%1.28B | -75.67%544.7M | -64.26%4.35B | -49.24%2.93B | -38.98%2.6B |
| Cash inflows from operating activities | -34.67%6.12B | -29.30%4.36B | -31.75%2.08B | -30.61%12.62B | -30.96%9.37B | -36.55%6.17B | -45.00%3.05B | -50.56%18.19B | -50.69%13.58B | -53.59%9.73B |
| Goods services cash paid | -41.70%3.47B | -40.87%2.52B | -43.48%1.59B | -35.07%8.8B | -44.47%5.96B | -38.30%4.27B | -20.59%2.81B | -27.62%13.56B | -24.83%10.73B | -26.61%6.91B |
| Staff behalf paid | -15.01%961.35M | -12.24%647.47M | -9.79%341.6M | -9.26%1.56B | -14.63%1.13B | -13.77%737.76M | -13.25%378.66M | -23.37%1.72B | -25.18%1.33B | -30.61%855.59M |
| All taxes paid | -33.53%522.12M | -22.69%405.63M | -15.27%166.57M | 3.22%1B | -8.54%785.55M | -16.82%524.66M | -11.40%196.59M | -64.11%971.4M | -66.63%858.91M | -68.89%630.77M |
| Cash paid relating to other operating activities | -28.27%1.74B | -14.27%1.18B | 409.50%465.05M | -13.77%2.96B | 40.94%2.43B | -23.99%1.38B | -94.73%91.28M | -68.46%3.43B | -73.84%1.73B | -57.66%1.81B |
| Cash outflows from operating activities | -34.98%6.7B | -31.12%4.76B | -26.33%2.56B | -27.21%14.32B | -29.59%10.31B | -32.38%6.91B | -41.37%3.48B | -43.05%19.67B | -41.94%14.64B | -39.79%10.21B |
| Net cash flows from operating activities | 38.04%-579.61M | 46.46%-392.54M | -12.43%-479.76M | -14.39%-1.7B | 12.13%-935.39M | -51.48%-733.1M | -11.02%-426.72M | -165.84%-1.48B | -146.03%-1.06B | -112.10%-483.96M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -99.66%140.19K | -99.66%140.19K | --100K | 2,115.19%42.54M | 5,800.26%40.94M | 5,857.57%40.94M | ---- | -99.79%1.92M | -99.92%693.93K | -99.92%687.21K |
| Cash received from returns on investments | ---- | ---- | ---- | -98.26%303.82K | -29.17%3.82K | -29.17%3.82K | ---- | 627.82%17.43M | -99.98%5.4K | -99.72%5.4K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -97.49%187.39K | 43.16%128.62K | -99.54%200 | -97.69%11.09M | -79.23%7.46M | -99.73%89.84K | -99.86%43.5K | 32,919.03%480.5M | 3,119.81%35.91M | 3,345.62%33.02M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | -65.13%16.41M | -46.05%16.41M | -46.04%16.41M | 144.62%31.8M | -98.52%47.06M | -99.03%30.41M | -98.42%30.41M |
| Cash received relating to other investing activities | --66.82K | --66.82K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | -99.39%394.4K | -99.42%335.63K | -99.69%100.2K | -87.14%70.34M | -3.29%64.82M | -10.41%57.44M | -32.46%31.84M | -87.87%546.91M | -98.33%67.02M | -97.68%64.12M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -88.74%9.62M | -94.39%4.36M | -96.90%2.2M | 208.49%94.55M | 56.91%85.37M | 150.62%77.73M | 195.84%71.13M | -76.49%30.65M | -48.19%54.41M | -62.52%31.02M |
| Cash paid to acquire investments | --150K | --150K | ---- | --17.05M | ---- | ---- | ---- | ---- | ---- | 5.94%40M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | --7K | -81.89%18.61M | -79.57%20.06M | --20.06M | ---- | 102,661.99%102.76M | 98,067.60%98.17M | ---- |
| Cash paid relating to other investing activities | -99.93%3.7K | -99.93%3.7K | ---- | --4.25M | 557,507,329.00%5.58M | 557,507,329.00%5.58M | -100.00%1 | ---- | -100.00%1 | -100.00%1 |
| Cash outflows from investing activities | -91.20%9.77M | -95.63%4.51M | -96.89%2.21M | 0.79%134.46M | -27.25%111M | 45.55%103.36M | 177.95%71.13M | -92.20%133.41M | -70.13%152.57M | -85.37%71.02M |
| Net cash flows from investing activities | 79.70%-9.38M | 90.90%-4.18M | 94.62%-2.11M | -115.51%-64.12M | 46.01%-46.19M | -566.15%-45.92M | -282.23%-39.28M | -85.23%413.5M | -102.44%-85.55M | -100.30%-6.89M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --27.55M | --150K | --150K | ---- | ---- | ---- | ---- | -27.06%48.24M | -40.21%42.18M | -20.52%39.63M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --27.55M | --150K | --150K | ---- | ---- | ---- | ---- | -27.06%48.24M | -40.21%42.18M | -20.52%39.63M |
| Cash from borrowing | 47.78%464.21M | 92.25%389.81M | 58.22%371.44M | -37.56%431.14M | -78.48%314.11M | -78.56%202.76M | 61.85%234.76M | -21.15%690.45M | 94.61%1.46B | 81.62%945.67M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | -96.26%603.3K | ---- | ---- | ---- |
| Cash inflows from financing activities | 56.55%491.76M | 92.32%389.96M | 57.88%371.59M | -41.63%431.14M | -79.08%314.11M | -79.42%202.76M | 43.30%235.37M | -23.92%738.69M | 49.63%1.5B | 67.71%985.3M |
| Borrowing repayment | -59.70%433.35M | -47.77%335.41M | -52.12%162.28M | -44.43%1.31B | -61.79%1.08B | -68.26%642.16M | -18.72%338.96M | -80.62%2.35B | -75.52%2.81B | -77.20%2.02B |
| Dividend interest payment | -67.38%83.12M | -71.10%61.39M | -81.41%28.78M | -56.27%409.28M | -63.84%254.84M | -60.58%212.44M | -37.29%154.84M | -67.63%935.9M | -72.81%704.67M | -73.40%538.92M |
| Cash payments relating to other financing activities | -28.05%28.59M | -13.91%18.5M | 259.94%30.67M | 3.37%57.68M | -45.55%39.74M | -68.29%21.49M | -68.41%8.52M | -86.90%55.8M | -83.47%72.98M | -73.90%67.76M |
| Cash outflows from financing activities | -60.21%545.06M | -52.60%415.3M | -55.86%221.74M | -46.94%1.78B | -61.86%1.37B | -66.69%876.09M | -27.30%502.33M | -78.37%3.35B | -75.28%3.59B | -76.44%2.63B |
| Net cash flows from financing activities | 94.95%-53.31M | 96.24%-25.34M | 156.13%149.85M | 48.44%-1.34B | 49.48%-1.06B | 59.06%-673.33M | 49.31%-266.96M | 82.01%-2.61B | 84.55%-2.09B | 84.45%-1.64B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 260.53%1.28M | 603.57%1.31M | 213.22%1.34M | -158.45%-1.14M | -137.73%-795.72K | -105.88%-260.78K | -726.24%-1.18M | -95.70%1.96M | -75.46%2.11M | 139.14%4.43M |
| Net increase in cash and cash equivalents | 68.55%-641.01M | 71.04%-420.74M | 54.96%-330.68M | 15.49%-3.11B | 37.05%-2.04B | 31.83%-1.45B | 17.48%-734.15M | 60.91%-3.67B | 57.92%-3.24B | 50.50%-2.13B |
| Add:Begin period cash and cash equivalents | -61.02%1.98B | -61.02%1.98B | -61.12%1.98B | -41.93%5.09B | -41.91%5.09B | -41.91%5.09B | -41.91%5.09B | -51.75%8.76B | -51.77%8.76B | -51.76%8.76B |
| End period cash equivalent | -55.99%1.34B | -57.02%1.56B | -62.16%1.65B | -61.02%1.98B | -44.77%3.05B | -45.15%3.64B | -44.68%4.36B | -41.93%5.09B | -47.24%5.53B | -52.15%6.63B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Beijing Chengyu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Beijing Chengyu Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.